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PolysomesAdhesion to ﬁbronectin stimulates protein synthesis (translation) of ﬁbroblasts. Protein synthesis stimulation
is dependent from the activation of β1-integrin. β1-Integrin elicits a PI3K cascade that modulates eIF4F
(eukaryotic initiation factor 4F) complex formation. In the attempt to further dissect elements of the PI3K
cascade that might be responsible for ﬁbronectin-stimulated translation, we used pharmacological inhibitors
of known kinases. We found that JNK inhibition, by SP600125 treatment, increased 35S-methionine
incorporation. Paradoxically, the increase in methionine incorporation was associated to a reduction of
initiation of translation. These data imply that, during the adhesion of ﬁbroblasts to ﬁbronectin, conspicuous
protein degradation occurs. Indeed, we found that inhibition of the proteasome by MG132 also increased
methionine incorporation. Cotranslational degradation depended on PI3K activation. In spite of this, serum
promoted translation, but not cotranslational degradation. The crosstalk between translation and degradation
was further analyzed by studying the phosphorylation of initiation factors. Brieﬂy, inhibition of JNK leads to
eIF2α phosphorylation, which may account for the decrease in initiation of translation. In conclusion, β1-
integrin-activated translation causes the synthesis of short-lived proteins, whose degradation is controlled by
the JNK pathway. We hypothesize that JNK is a general regulator of cotranslational degradation.2 Milano, Italy. Tel.: +39
c, Canada H3G 1Y6.
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Adhesion to extracellular matrix is coordinated by integrin
receptors and is fundamental in biological processes like migration,
survival, proliferation, and tumorigenesis [1,2]. Integrins are dimeric
transmembrane glycoproteins that act as extracellular matrix recep-
tors [3] activating cytoskeletal rearrangement [4,5] and various
intracellular signals [6,7]. Integrins affect gene expression also at the
level of translation. Adhesion and activation of β3- [8,9], β4- [10,11],
and β1-integrins [12,13] led to the translation of speciﬁc mRNAs
modulating cellular response, both in normal and pathological
conditions. Contributing to this scenario, we have previously shown
that β1 integrin controls translation during adhesion to ﬁbronectin,
through the modulation of the initiation phase. Intriguingly, β1-
integrin controls translation through a PI3 kinase (PI3K)-dependent
but mTOR-independent pathway [12].
The rate of initiation of translation is affected by the activity of
initiation factors. One mechanism is due to initiation complex eIF4F
formation: initiation factors eIF4E, eIF4G, and eIF4A assume a
hierarchical organization on m7GpppX-cap structure recruiting ribo-
somes onto the messenger RNA (mRNA) [14,15]. 4E binding proteins(4E-BPs) are inhibitory factors preventing eIF4F formation by binding
eIF4E and replacing eIF4G [16,17]. In response to growth factors,
eIF4E-BPs are hyperphosphorylated and released from eIF4E, allowing
eIF4G recruitment on eIF4E [18]. Phosphorylation of eIF4E-BPs usually
occurs by stimulation of the FRAP/TOR pathway [18,19]. In addition,
eIF4E is phosphorylated by Mnk1 and Mnk2 at Ser209 in mammals
[20]; stress by anysomicin activates stress-activated protein kinase
(JNK/SAPK) in quiescent NIH3T3 cells, which also leads to eIF4E
phosphorylation [21]. The molecular mechanism by which eIF4E
phosphorylation acts is uncertain, but it is understood that it increases
tumorigenesis [22]. A second regulatory step converges on eIF2α
subunit. eIF2 is a GTPase that stabilizes Met-tRNA binding to the
ribosome through ternary complex (eIF2-GTP-tRNA(i)Met) formation
[23,24]. eIF2α phosphorylation blocks eIF2-GDP and eIF2B in a
complex with reduced guanine nucleotide exchange factor activity.
The resulting reduction in eIF2-GTP levels leads to the inhibition of the
overall rate of protein synthesis [25,26], repressing translation of most
mRNAs [12,27,28]. In this context, an important shut-off of translation
is observed through the activation of PERK (PKR-like ER kinase) and
phosphorylation of eIF2α, during the unfolded protein response
[29,30]. The unfolded protein response (UPR) occurs in the endo-
plasmic reticulum (ER) when unfolded proteins are not degraded by
proteasomes and accumulate in ER [31]. Signaling pathways control-
ling proteasome activity are poorly understood.
It was reported that some cells degrade up to 30% of nascent
polypeptides by the proteasome within 10 min from their synthesis,
827V. Gandin et al. / Biochimica et Biophysica Acta 1803 (2010) 826–831possibly recognizing their unfolded structure [32]. Presumably, cells
rapidly destroy defective ribosomal products (DRiPs) to avoid them
interfering with the function of useful cellular components and/or to
present them on the MHC1. The biochemical pathways controlling DRiPs
formation and the relationship to cellular events and translation are
unclear [33]. In thiswork,we found that, during adhesion toﬁbronectin, a
large portion of proteins is cotranslationally degraded.We found that the
c-Jun N-terminal kinase (JNK) is involved in cotranslational degradation
of newly synthesized proteins downstream the PI3K pathway, suggesting
that DRiPs formation is a process linked to extracellular signaling,
particularly prominent during adhesion to matrix.
2. Materials and methods
2.1. Antibodies and Western blot
Polyclonal antibodies: anti -eIF4E, phospho-eIF4E (Ser209), phos-
pho-c-Jun (Ser63), -eIF2α, and phospho-eIF2α (Ser-51) were fromFig. 1. JNK inhibition affects cytoskeletal remodelling and 35S-methionine incorporation. (
Immunoﬂuorescence staining of actin ﬁlaments in untreated (left) or treated cells (right). S
(FN), treated (FN+SP), and suspended ﬁbroblasts (SUSP). p value is indicated. (C) Effects o
inhibition affects 35S-methionine incorporation during adhesion. (D) Effect of SP600125 (P
SP600125 treatment at 10 µM, 20 µM, and 50 µM compared to untreated cells (FN). (G) Effec
and c-Jun phosphorylation following JNKKCAA expression, measured by Western blot and dCell Signaling Technology; phospho-JNK was kindly provided by
Tiziana Borsello. Monoclonal anti-β-actin was from Sigma-Aldrich.
Western blot analysis was carried out as described in Gorrini et al.
[12]. Densitometric analysis was performed by using ImageJ, a free
image analyzing software program (National Institutes of Health,
Bethesda, MD).
2.2. Adhesion assay, transfection, and immunoﬂuorescence
The adhesion assay was performed as described [12]. For treated
cells, the adhesion assay was performed either in the presence of
LY294002 (Alexis Pharmaceutical), SB203580 (Calbiochem), or
SP600125 (Calbiochem) and/or MG132 (Sigma). NIH3T3 cells were
transfected with pET15b-JNK2α2 [34] as described [35]. Experiments
with SP600125 were performed from 10 to 50 μM, with qualitatively
similar results. For immunoﬂuorescence, NIH3T3 ﬁbroblasts were
ﬁxed with formaldehyde and permeabilized, and F-actin was stained
as previously described [36,37].A) NIH3T3 ﬁbroblasts were plated on ﬁbronectin and treated with 50 µM SP600125.
cale bar indicates 10 µm. (B) 35S-Methionine incorporation was measured in untreated
f MAPK inhibitors on cotranslational degradation. Data indicate that JNK but not MAPK
lastic+SP) on cycling cells growing on plastic (Plastic). (E) Dose-dependent effect of
ts of JNKK2 mutants on cotranslational degradation and the relative (F) increase in JNK
ensitometric analyses (n=3).
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35S-Methionine labeling was performed as previously described.
Data are expressed as mean of three independent experiments [38].
Statistical P value is calculated by Student's test. Polysomal proﬁles
were performed as described [38]. For pulse chase, NIH3T3 were
replated on 30 µg/ml of ﬁbronectin and pulsed with 10 µCi/ml of 35S-
Pro-Mix (35S-Methionine/Cysteine mixture; Amersham), as de-
scribed speciﬁcally. After the pulse, DMEM without methionine and
cysteine (Sigma-Aldrich) containing 35S-ProMix was replaced with 3
volumes of DMEM. Cells were lysed after 60 min, and the radioactive
content was measured as previously described [38].
Fluorography was performed by running equal amounts of
proteins (40 µg) on 10% SDS–PAGE. Gels were stainedwith Coomassie
brilliant blue, destained, enhanced with 1 M sodium salicylate for
1 hour, dried, and exposed to X-ray ﬁlms for 4 days.
3. Results
3.1. SP600125 treatment affects cytoskeleton remodelling, increases
35S-methionine incorporation, but inhibits initiation of translation
Recently, we have shown that adhesion to ﬁbronectin increases
translation through a PI3K-dependent, but mTORC1-independent
pathway, activated by β1-integrin [12]. We analyzed whether JNK
could be involved in adhesion-stimulated translation. Adhesion to
ﬁbronectin causes stimulation of JNK activity during the ﬁrst minutes
of adhesion [39], and evidence suggests that JNK pathway is required
for cell migration [40,41]. During adhesion to ﬁbronectin, JNK was
blocked by SP600125, an ATP binding competitor that inhibits JNK
phosphorylation [42]. Inhibition of JNK kinase activity inhibited actinFig. 2. JNK inhibition affects initiation phase of translation through eIF4E and eIF2α inactiva
SP600125 (FN+SP) or with SB203580 (FN+SB). Ratio between 80S and polysomes are ind
translation in SP-treated but not in SB-treated cells. (B and C) Effects of SP on eIF2α and eIF4
as an ER stress control in WB for eIF2α phosphorylation. Data were normalized with anti-eremodeling (Fig. 1A). We measured methionine incorporation in the
presence of JNK inhibitor. Surprisingly, JNK inactivation also increased
35S-methionine incorporation compared to untreated cells (Fig. 1B).
Inhibition of related MAPK by SB203580 did not affect methionine
incorporation (Fig. 1C). Inhibition of JNK in cycling cells, not adhering
on ﬁbronectin, also did not change methionine incorporation
(Fig. 1D). SP600125 caused an increase of methionine incorporation
in doses as low as 10 μM (Fig. 1E). Finally, a constitutively active
mutant of a JNK kinase, the JNKK2CAA mutant protein, decreased
methionine incorporation compared to cells transfected with the
kinase dead JNKK2AAA (Fig. 1F). Jnk inhibition by SP600125 resulted in
inhibition of phosphorylation of JNK target P-Jun (Supplementary
Fig. 1). Taken together, these data suggest that JNK inhibition, but only
in cells that are spreading on ﬁbronectin, causes a puzzling increase in
methionine incorporation.
To investigate whether the average increment in 35S-methionine
incorporation was due to an increase in initiation of translation, we
analyzed the amount of polysomes, during adhesion and with or
without SP600125 treatment (Fig. 2A). Surprisingly, JNK inhibition
caused 80S ribosome subunit accumulation, a marker for initiation
defects, and, at the same time, polysomes reduction. Inhibition of
MAPK did not cause changes in polysomal proﬁles. These data
unequivocally show that in cells treated with SP600125, a deﬁcit in
the initiation phase of translation is occurring, despite increased 35S-
methionine incorporation.
Next, we analyzed the phosphorylation of eIF2α and eIF4E upon
SP600125 treatment. Treatment of cells with SP600125 induced eIF2α
phosphorylation (Fig. 2B) and eIF4E dephosphorylation (Fig. 2C). These
data suggest that the eIF2 complex is inactivated by JNK inhibition and
may explain the increase in 80S formation. eIF2α phosphorylation is a
bona-ﬁdemarker for the unfolded protein response (UPR) that involvestion. (A) Polysomal proﬁle of NIH3T3 ﬁbroblasts untreated (FN) or treated either with
icated. Increase of 80S and decreased polysomes reveal defects in the initiation phase of
E phosphorylation and relative densitometric analysis (n=6). DTT treatment was used
IF2α and anti-eIF4E, respectively.
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the rate of cotranslational degradation during replating of ﬁbroblast on
ﬁbronectin.
3.2. JNK inhibition may affect cotranslational degradation
Stability of newly synthesized proteins was analyzed with a ﬁrst
experiment in which 30 min labelling was followed by 45 min of
chase. In these conditions, SP600125 treatment resulted in consistent
increase of incorporated methionine (Fig. 3A, left; Supplementary
Fig. 2). Next, we performed a very short pulse with methionine,
followed by 60 min of chase, analyzing both incorporation at early
time and at prolonged time (Fig. 3A, right). Data show that, at a short
time, SP600125 cells incorporate less (note, in agreement with
polysomal proﬁle data of Fig. 2). However, incorporated methionine
is not lost upon chase, in the presence of SP600125, but it is lost in
control cells. In conclusion, Fig. 3A shows that SP600125 treatmentFig. 3. SP600125 arrests cotranslational degradation in NIH3T3 ﬁbroblasts during adhesi
measured in NIH3T3 cells replated on ﬁbronectin without (FN) or with (FN+SP) SP600
experiment. Incorporation rate at 10 min and 1 hour of chase. SP-treated cells incorporate
incorporation was measured and the effect of SP600125 (50 µM; FN+SP), MG132 (10 µM
adhesion. SP600125 treatment signiﬁcantly increased 35S-methionine incorporation; MG13
following SP600125 treatment during adhesion- (on ﬁbronectin) and serum-stimulated tran
proteins synthesized in response to cell–matrix adhesion but not to serum. p value is indicinduces a translationdeﬁcit and a block in degradation, suggesting that
cotranslational degradation is blocked by Jnk inhibition (as in Fig. 1F).
To investigate whether the proteasome was involved in JNK-
mediated protein degradation, ﬁbroblasts were treated with the
proteasome inhibitor MG132 in the ﬁrst hour of adhesion. MG132
treatment results in an increase of 35S-methionine incorporation,
although to a lesser extent than SP600125. Furthermore, we observed
additive incorporation, when cells were treated with a mixture of the
two inhibitors. These data suggest that the process of cotranslational
degradation mediated by JNK may involve both the proteasome, as
well as additional components of the proteolytic pathways (Fig. 3B).
Next, we investigated whether JNK-induced protein degradation
was speciﬁc for adhesion-stimulated translation. A common stimu-
lator of translation is serum. Neither methionine incorporation nor
cell shape was affected by JNK inhibition in the presence of serum
(Fig. 3C). Thus, JNK controls cotranslational degradation only during
attachment of cells to matrix.on-stimulated translation. (A) Stability and synthesis of newly synthesized proteins
125. Left, Long-term chase of metabolically labelled protein. Right, Pulse and chase
less (time 10) but do not degrade as shown by their ﬂat slope. (B) 35S-Methionine
; FN+MG), and SP600125+MG132 (FN+SP+MG) treatment was analyzed during
2 also caused an accumulation of labelled proteins. (C) 35S-Methionine incorporation
slation (on dish plus serum). SP600125 treatment affects cotranslational degradation of
ated.
Fig. 4. SP600125 inhibits cotranslational degradation of proteins translated in a PI3K-
dependent fashion. (A) During adhesion on ﬁbronectin, NIH3T3 cells were untreated or
treated with LY294002 (LY), LY294002 plus SP600125 (LY+SP), or SP600125 (SP). (B)
Representative western blot analysis of JNK activation in the condition described above.
JNK activation was analyzed with phospho-JNK. Data were normalized with anti-β-
actin. JNK phosphorylation is inhibited by its inhibitor but not by PI3K inhibitor.
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cotranslational degradation
We previously demonstrated that β1-integrin activation leads to
increased protein synthesis through a PI3K-dependent pathway that
acts on eIF4F complex formation and eIF2α [12]. The arising question
is whether JNK controls protein degradation downstream of PI3K
activation. We found that NIH3T3 ﬁbroblasts treated at the same time
with PI3K inhibitor LY294002 and SP600125 did not accumulate
labelled proteins compared to SP600125 treated cells (Fig. 4A).
Furthermore, Western blot analysis shows that LY294002 does not
affect JNK kinase phosphorylation (Fig. 4B). Taken together, these data
show that, during adhesion to ﬁbronectin, the increase of translation
is accompanied by cotranslational degradation, which can be blocked
by JNK inhibition.
4. Discussion
Translational control requires a complex series of signalling
cascades that ultimately converge onto initiation factors. In the past,
we have shown that adhesion of mouse ﬁbroblasts to ﬁbronectin
induces a burst of protein synthesis, which can be inhibited by PI3K
blockade but not bymTOR blockade [12]. The increase of translation in
ﬁbroblasts adhering to ﬁbronectin was as strong as the increase of
translation elicited by serum [12]. To pharmacologically dissect the
pathway regulating translation, during adhesion, we used JNK
inhibitor SP600125. Here we made the surprising observation that
SP600125 caused simultaneously an increase in 35S-methionine
incorporation and a decrease in initiation of translation. The dose
response at which we observed SP600125 effects was in the range of
20–50 μM, suggesting that only at higher doses did we achieve
plateau inhibition or, alternatively, a contribution due to unspeciﬁc
SP600125 effects; however, we observed similar effects by transfect-
ing Jnk mutants, thus suggesting a speciﬁc contribution of Jnk kinase.
The following analysis showed that stimulation of ﬁbronectin induces
not only translation but also degradation of short-lived proteins. It is
possible that JNK plays a general role in linking translation anddegradation, depending upon extracellular stimuli. For instance, we
may speculate that activation of JNK upon stressful stimuli would
elicit degradation pathways, increasing the control over misfolded
proteins. This hypothesis is indirectly supported by the increase of the
phosphorylation of eIF2α, in the presence of JNK inhibition. eIF2α
phosphorylation is associated with several stressful stimuli, among
them the unfolded protein response [30,43]. It is known since some
time that misfolded proteins in the endoplasmic reticulum (ER)
induce cellular stress and activate c-Jun amino-terminal kinases (JNKs
or SAPKs) [44,45]. Here, we also provide evidence that inactivation of
the JNK pathway results in blocked degradation and increase of eIF2α
phosphorylation, which is to say that JNK is amid the degradation
pathway and control of initiation. The impact of JNK activation on
translational control may enclose initiation of translation. Phosphor-
ylation of eIF4E, on the Mnk cascade [46,47], may contribute to a
qualitative and quantitative modulation of translation [48,49]. In our
conditions, JNK inhibition reduces eIF4E phosphorylation, in line with
previous reports [50], thus suggesting that JNK may also shape the
selection of translated mRNAs.
The relationship between translation and protein degradation is an
intriguing and poorly understood topic. Although it seems obvious
that the two events are correlated, open questions remain on how
they crosstalk, the biochemical pathways controlling their interaction,
and the physiological meaning. We will suggest some ideas. Some
cells degrade up to 30% of nascent polypeptides by the proteasome
within 10 min from their synthesis, possibly recognizing their
unfolded structure [32]. It is conceivable that cells rapidly destroy
defective ribosomal products (DRiPs) to avoid them interfering with
the function of cellular components and/or to present them on the
major histocompatibility complex 1. In this context, the fact that we
observed consistent degradation of proteins, during adhesion of cells
to ﬁbronectin, may suggest that, in vivo, cotranslational degradation is
linked to spatially localized signals, such as the ones occurring during
adhesion of cells to extracellular matrix. We speculate that cotransla-
tional degradation during adhesion may be signiﬁcant in cells
exposing defective ribosomal products (DRiPs) on their MHC1. For
instance, microglial activation and transformation in antigen-pre-
senting cells are promoted by ﬁbronectin [51].
In conclusion, we have provided evidence that in cultured
ﬁbroblasts, adhesion to extracellular matrix is accompanied by a
burst of proteins synthesis, as well as by cotranslational degradation.
Cotranslational degradation can be blocked by inhibition of JNK,
suggesting an involvement of this kinase in linking initiation of
translationwith degradation. In addition, JNK inhibition results also in
a reduction in the rate of translation initiation, in line with the
hypothesis that an extensive crosstalk between protein degradation
and initiation of translation exists.
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